Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-19-020742

EVP, Research and Development gave up 960 shares (to pay taxes)

  • EVP, Research and Development acquired 1,126 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ehlers Michael D EVP, Research and Development 2019-06-01 Shares withheld for taxes −460 $219.29 $100,873 7,399.22 D: show line 1 in the form
Ehlers Michael D EVP, Research and Development 2019-06-01 Option exercise +1,126 8,525.22 D: show line 2 in the form
Ehlers Michael D EVP, Research and Development 2019-06-01 Shares withheld for taxes −500 $219.29 $109,645 8,025.22 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ehlers Michael D EVP, Research and Development 2019-06-01 Option exercise · Restricted Stock Unit −1,126 $0.00 2019-06-01 1,126 1,376 D: show line 4 in the form
Ehlers Michael D EVP, Research and Development 2019-06-01 Other disposition · Restricted Stock Unit −1,376 $0.00 2019-06-01 1,376 0 D: show line 5 in the form
Loading xslF345X03/form4.xml…